- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: International journal of molecular sciences, 18.2017, Nr. 11, Art. 2469, doi:10.3390/ijms18112469
- Schlagwort
-
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Universitätsbibliothek Johann Christian Senckenberg
- (wann)
-
2017
- Urheber
-
Burger, Michael C.
Breuer, Stella
Cieplik, Hans
Harter, Patrick Nikolaus
Franz, Kea
Bähr, Oliver
Steinbach, Joachim Peter
- URN
-
urn:nbn:de:hebis:30:3-451626
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:49 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Burger, Michael C.
- Breuer, Stella
- Cieplik, Hans
- Harter, Patrick Nikolaus
- Franz, Kea
- Bähr, Oliver
- Steinbach, Joachim Peter
- Universitätsbibliothek Johann Christian Senckenberg
Entstanden
- 2017
Ähnliche Objekte (12)
Bevacizumab for patients with recurrent gliomas presenting with a gliomatosis cerebri growth pattern
Myoinositol as a biomarker in recurrent glioblastoma treated with bevacizumab : a 1H-magnetic resonance spectroscopy study
Adrenal insufficiency in patients with corticosteroid-refractory cerebral radiation necrosis treated with bevacizumab
Sorafenib in patients with refractory or recurrent multiple myeloma
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
Atezolizumab plus bevacizumab in patients with advanced and progressing hepatocellular carcinoma: retrospective multicenter experience
Chondral injuries in patients with recurrent patellar dislocation: a systematic review
A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
Epstein-Barr virus genes in patients with acute, chronic and recurrent hemophagocytosis
Single-shot bevacizumab for cerebral radiation injury
Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer
Bevacizumab for patients with recurrent gliomas presenting with a gliomatosis cerebri growth pattern
Myoinositol as a biomarker in recurrent glioblastoma treated with bevacizumab : a 1H-magnetic resonance spectroscopy study
Adrenal insufficiency in patients with corticosteroid-refractory cerebral radiation necrosis treated with bevacizumab
Sorafenib in patients with refractory or recurrent multiple myeloma
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
Atezolizumab plus bevacizumab in patients with advanced and progressing hepatocellular carcinoma: retrospective multicenter experience
Chondral injuries in patients with recurrent patellar dislocation: a systematic review
A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
Epstein-Barr virus genes in patients with acute, chronic and recurrent hemophagocytosis
Single-shot bevacizumab for cerebral radiation injury
Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer
Bevacizumab for patients with recurrent gliomas presenting with a gliomatosis cerebri growth pattern
Myoinositol as a biomarker in recurrent glioblastoma treated with bevacizumab : a 1H-magnetic resonance spectroscopy study
Adrenal insufficiency in patients with corticosteroid-refractory cerebral radiation necrosis treated with bevacizumab
Sorafenib in patients with refractory or recurrent multiple myeloma
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
Atezolizumab plus bevacizumab in patients with advanced and progressing hepatocellular carcinoma: retrospective multicenter experience
Chondral injuries in patients with recurrent patellar dislocation: a systematic review
A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
Epstein-Barr virus genes in patients with acute, chronic and recurrent hemophagocytosis
Single-shot bevacizumab for cerebral radiation injury